Neurizon Therapeutics Limited (ASX:NUZ)
0.0820
-0.0010 (-1.20%)
At close: Mar 6, 2026
-34.40% (1Y)
| Market Cap | 57.29M |
| Revenue (ttm) | 5.98M |
| Net Income (ttm) | -14.85M |
| Shares Out | 698.63M |
| EPS (ttm) | -0.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 771,201 |
| Average Volume | 560,007 |
| Open | 0.0830 |
| Previous Close | 0.0830 |
| Day's Range | 0.0820 - 0.0830 |
| 52-Week Range | 0.0790 - 0.1850 |
| Beta | 1.27 |
| RSI | 36.44 |
| Earnings Date | Feb 26, 2026 |